GNOG.L vs. HEAW.L

Last updated Apr 2, 2026

Compare and contrast key facts about Global X Genomics & Biotechnology UCITS ETF (GNOG.L) and SPDR MSCI World Health Care UCITS ETF (HEAW.L).

GNOG.L and HEAW.L are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. GNOG.L is a passively managed fund by Global X that tracks the performance of the MSCI World/Health Care NR USD. It was launched on Nov 2, 2021. HEAW.L is a passively managed fund by State Street that tracks the performance of the MSCI World/Health Care NR USD. It was launched on Apr 29, 2016. Both GNOG.L and HEAW.L are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Performance

GNOG.L vs. HEAW.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Global X Genomics & Biotechnology UCITS ETF (GNOG.L) and SPDR MSCI World Health Care UCITS ETF (HEAW.L). The values are adjusted to include any dividend payments, if applicable.

GNOG.L vs. HEAW.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
GNOG.L Global X Genomics & Biotechnology UCITS ETF	-1.16%	12.03%	-16.98%	-11.35%	-13.86%
HEAW.L SPDR MSCI World Health Care UCITS ETF	-2.68%	7.46%	2.52%	-2.05%	5.82%

Returns By Period

In the year-to-date period, GNOG.L achieves a -1.16% return, which is significantly higher than HEAW.L's -2.68% return.

GNOG.L

• 1D: 3.29%
• 1M: -4.36%
• YTD: -1.16%
• 6M: 14.72%
• 1Y: 37.00%
• 3Y*: -4.91%
• 5Y*: —
• 10Y*: —

HEAW.L

• 1D: 1.16%
• 1M: -5.20%
• YTD: -2.68%
• 6M: 5.46%
• 1Y: 2.93%
• 3Y*: 3.24%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

GNOG.L vs. HEAW.L - Expense Ratio Comparison

GNOG.L has a 0.50% expense ratio, which is higher than HEAW.L's 0.30% expense ratio.

GNOG.L

Global X Genomics & Biotechnology UCITS ETF

HEAW.L

SPDR MSCI World Health Care UCITS ETF

Return for Risk

GNOG.L vs. HEAW.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GNOG.L

GNOG.L Risk / Return Rank: 64
GNOG.L Sharpe Ratio Rank: 66
GNOG.L Sortino Ratio Rank: 67
GNOG.L Omega Ratio Rank: 54
GNOG.L Calmar Ratio Rank: 73
GNOG.L Martin Ratio Rank: 59

HEAW.L

HEAW.L Risk / Return Rank: 17
HEAW.L Sharpe Ratio Rank: 16
HEAW.L Sortino Ratio Rank: 15
HEAW.L Omega Ratio Rank: 15
HEAW.L Calmar Ratio Rank: 20
HEAW.L Martin Ratio Rank: 17

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GNOG.L vs. HEAW.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GNOG.L) and SPDR MSCI World Health Care UCITS ETF (HEAW.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	GNOG.L	HEAW.L	Difference
Sharpe ratio Return per unit of total volatility	1.23	0.19	+1.04
Sortino ratio Return per unit of downside risk	1.79	0.37	+1.42
Omega ratio Gain probability vs. loss probability	1.22	1.05	+0.17
Calmar ratio Return relative to maximum drawdown	2.22	0.42	+1.80
Martin ratio Return relative to average drawdown	6.61	0.83	+5.78
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

GNOG.L vs. HEAW.L - Sharpe Ratio Comparison

The current GNOG.L Sharpe Ratio is 1.23, which is higher than the HEAW.L Sharpe Ratio of 0.19. The chart below compares the historical Sharpe Ratios of GNOG.L and HEAW.L, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	GNOG.L	HEAW.L	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.23	0.19	+1.04
Sharpe Ratio (All Time) Calculated using the full available price history	-0.45	0.21	-0.65

Correlation

The correlation between GNOG.L and HEAW.L is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

GNOG.L vs. HEAW.L - Dividend Comparison

Neither GNOG.L nor HEAW.L has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

GNOG.L vs. HEAW.L - Drawdown Comparison

The maximum GNOG.L drawdown since its inception was -67.50%, which is greater than HEAW.L's maximum drawdown of -18.85%. Use the drawdown chart below to compare losses from any high point for GNOG.L and HEAW.L.

Drawdown Indicators

	GNOG.L	HEAW.L	Difference
Max Drawdown Largest peak-to-trough decline	-67.50%	-18.85%	-48.65%
Max Drawdown (1Y) Largest decline over 1 year	-17.16%	-10.30%	-6.86%
Current Drawdown Current decline from peak	-48.74%	-5.95%	-42.79%
Average Drawdown Average peak-to-trough decline	-44.07%	-5.49%	-38.58%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.75%	4.77%	+0.98%

Volatility

GNOG.L vs. HEAW.L - Volatility Comparison

Global X Genomics & Biotechnology UCITS ETF (GNOG.L) has a higher volatility of 9.63% compared to SPDR MSCI World Health Care UCITS ETF (HEAW.L) at 4.26%. This indicates that GNOG.L's price experiences larger fluctuations and is considered to be riskier than HEAW.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GNOG.L	HEAW.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.63%	4.26%	+5.37%
Volatility (6M) Calculated over the trailing 6-month period	21.09%	8.88%	+12.21%
Volatility (1Y) Calculated over the trailing 1-year period	29.88%	15.32%	+14.56%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	31.32%	12.97%	+18.35%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	31.32%	12.97%	+18.35%